Beacon Discovery has entered a multi-year drug discovery collaboration with Takeda focused on a number of G-protein coupled receptors (GPCRs) that play an important role in the pathology of gastrointestinal disorders.   Through the collaboration, Beacon will leverage its GPCR drug discovery expertise to identify drug candidates for a range of GI diseases with significant unmet medical need.    “This collaboration represents another exciting milestone in the development of k...